Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (298)
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,138
Price
$119.36
Total Value
$135.84K
Shares Held After
4,700
% of Holdings
19.5%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
412
Price
$118.49
Total Value
$48.82K
Shares Held After
5,838
% of Holdings
6.6%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
622
Price
$124.61
Total Value
$77.51K
Shares Held After
6,250
% of Holdings
9.1%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
5,253
Price
$123.81
Total Value
$650.37K
Shares Held After
6,872
% of Holdings
43.3%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
6,223
Price
$123.07
Total Value
$765.87K
Shares Held After
12,125
% of Holdings
33.9%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,115
Price
$121.84
Total Value
$135.85K
Shares Held After
18,348
% of Holdings
5.7%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,828
Price
$120.66
Total Value
$220.57K
Shares Held After
19,463
% of Holdings
8.6%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
3,639
Price
$119.36
Total Value
$434.37K
Shares Held After
21,291
% of Holdings
14.6%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,320
Price
$118.49
Total Value
$156.40K
Shares Held After
24,930
% of Holdings
5.0%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
20,000
Price
$2.05
Total Value
$41.04K
Shares Held After
386,904
% of Holdings
5.2%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
35,770
Price
$0.32
Total Value
$11.45K
Shares Held After
107,429
% of Holdings
25.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
100,019
Price
$22.79
Total Value
$2.28M
Shares Held After
875,912
% of Holdings
10.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
127,182
Price
$22.79
Total Value
$2.90M
Shares Held After
1,217,537
% of Holdings
9.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
253,039
Price
$22.79
Total Value
$5.77M
Shares Held After
4,223,448
% of Holdings
5.7%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$18.69
Total Value
$331.13K
Shares Held After
159,744
% of Holdings
10.0%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
5,889
Price
$50.84
Total Value
$299.42K
Shares Held After
41,884
% of Holdings
12.3%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
4,111
Price
$49.98
Total Value
$205.48K
Shares Held After
47,773
% of Holdings
7.9%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
2,474
Price
$87.03
Total Value
$215.31K
Shares Held After
60,299
% of Holdings
3.9%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
10,090
Price
$86.32
Total Value
$870.97K
Shares Held After
60,299
% of Holdings
14.3%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
8,786
Price
$85.35
Total Value
$749.89K
Shares Held After
70,389
% of Holdings
11.1%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
385
Price
$86.34
Total Value
$33.24K
Shares Held After
60,299
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
426
Price
$85.28
Total Value
$36.33K
Shares Held After
60,684
% of Holdings
0.7%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
745
Price
$86.38
Total Value
$64.35K
Shares Held After
105,272
% of Holdings
0.7%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
645
Price
$85.84
Total Value
$55.37K
Shares Held After
106,017
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,036
Price
$84.41
Total Value
$87.45K
Shares Held After
106,662
% of Holdings
1.0%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
387
Price
$83.10
Total Value
$32.16K
Shares Held After
107,698
% of Holdings
0.4%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
601
Price
$86.38
Total Value
$51.91K
Shares Held After
105,272
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
519
Price
$85.84
Total Value
$44.55K
Shares Held After
105,873
% of Holdings
0.5%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
833
Price
$84.41
Total Value
$70.31K
Shares Held After
106,392
% of Holdings
0.8%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
313
Price
$83.10
Total Value
$26.01K
Shares Held After
107,225
% of Holdings
0.3%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
8,660
Price
$18.71
Total Value
$162.03K
Shares Held After
409,897
% of Holdings
2.1%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
1,710
Price
$124.79
Total Value
$213.39K
Shares Held After
194,309
% of Holdings
0.9%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
1,975
Price
$123.74
Total Value
$244.39K
Shares Held After
196,019
% of Holdings
1.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
4,181
Price
$122.34
Total Value
$511.50K
Shares Held After
197,994
% of Holdings
2.1%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
12,134
Price
$121.65
Total Value
$1.48M
Shares Held After
202,175
% of Holdings
5.7%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
300
Price
$124.94
Total Value
$37.48K
Shares Held After
42,181
% of Holdings
0.7%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
528
Price
$123.84
Total Value
$65.39K
Shares Held After
42,481
% of Holdings
1.2%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
1,048
Price
$122.43
Total Value
$128.31K
Shares Held After
43,009
% of Holdings
2.4%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
3,124
Price
$121.67
Total Value
$380.10K
Shares Held After
44,057
% of Holdings
6.6%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
25,000
Price
$80.17
Total Value
$2.00M
Shares Held After
830,073
% of Holdings
2.9%
ALUMIS INC. (ALMS)
Pangali Sanam — Chief Legal Officer
Shares
5,000
Price
$28.00
Total Value
$140.00K
Shares Held After
11,111
% of Holdings
31.0%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
30,000
Price
$123.72
Total Value
$3.71M
Shares Held After
324,879
% of Holdings
8.5%
Oric Pharmaceuticals, Inc. (ORIC)
Heyman Richard A. — Director
Shares
300
Price
$12.00
Total Value
$3.60K
Shares Held After
212,772
% of Holdings
0.1%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
7,448
Price
$110.60
Total Value
$823.75K
Shares Held After
60,486
% of Holdings
11.0%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
4,854
Price
$109.02
Total Value
$529.18K
Shares Held After
67,934
% of Holdings
6.7%
Larimar Therapeutics, Inc. (LRMR)
Hamilton Thomas Edward — Director
Shares
50,000
Price
$3.34
Total Value
$166.89K
Shares Held After
714,798
% of Holdings
7.0%
Simulations Plus, Inc. (SLP)
DiBella John Anthony II — Chief Revenue Officer
Shares
1,000
Price
$18.36
Total Value
$18.36K
Shares Held After
86,140
% of Holdings
1.1%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
10,000
Price
$60.00
Total Value
$600.00K
Shares Held After
201,047
% of Holdings
4.7%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
1,400
Price
$17.04
Total Value
$23.86K
Shares Held After
9,173,053
% of Holdings
0.0%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
600
Price
$36.02
Total Value
$21.61K
Shares Held After
88,240
% of Holdings
0.7%
Showing 51–100 of 298 transactions (page 2 of 6)